My father, 65 years old, was diagnosed with B Cell Prolymphocitic Leukemia in March 2017. He received 6 cycles of Chemotherapy (Rituximab+Bendamestine) Aug. 17 to Jan. 18.
Before chemo Spleen size became 29 cm and after chemo it reduced to 20 cm and blood figures became satisfactory.
After chemo he faced repeated chest infections and got hospitalized thrice.
The disease relapsed in Jan. 18 and now he is taking "ibrutinib" (Bangladesh made) from last 3 months.
Now he is hospitalized again for chest infection and flu. He is feeling severe fatigue and even can't talk. Haemoglobin dropped to 7.3 and received 500ml packed cells blood. His Haematologist is satisfied with blood but spleen size has again enlarged to 29.6 cm.
Is ibrutinib last option for the disease ? And can US made ibrutinib make difference ?
Please advise.
Aftab Khan
Quetta, Pakistan